Washington Trust Advisors’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.83M | Buy |
112,962
+73
| +0.1% | +$5.71K | 0.72% | 38 |
|
|
2025
Q1 | $8.18M | Sell |
112,889
-521
| -0.5% | -$37.8K | 0.73% | 38 |
|
|
2024
Q4 | $8.4M | Sell |
113,410
-2,250
| -2% | -$167K | 0.7% | 40 |
|
|
2024
Q3 | $7.63M | Buy |
115,660
+23,489
| +25% | +$1.55M | 0.66% | 42 |
|
|
2024
Q2 | $8.51M | Sell |
92,171
-2,596
| -3% | -$240K | 0.78% | 36 |
|
|
2024
Q1 | $9.06M | Sell |
94,767
-2,175
| -2% | -$208K | 0.83% | 36 |
|
|
2023
Q4 | $7.39M | Buy |
96,942
+24,142
| +33% | +$1.84M | 0.71% | 40 |
|
|
2023
Q3 | $5.04M | Buy |
72,800
+86
| +0.1% | +$5.96K | 0.52% | 45 |
|
|
2023
Q2 | $6.86M | Sell |
72,714
-10
| -0% | -$943 | 0.67% | 44 |
|
|
2023
Q1 | $6.02M | Sell |
72,724
-318
| -0.4% | -$26.3K | 0.61% | 46 |
|
|
2022
Q4 | $5.45M | Buy |
73,042
+6,450
| +10% | +$481K | 0.6% | 45 |
|
|
2022
Q3 | $5.5M | Sell |
66,592
-2,586
| -4% | -$214K | 0.52% | 52 |
|
|
2022
Q2 | $6.58M | Sell |
69,178
-4,144
| -6% | -$394K | 0.58% | 50 |
|
|
2022
Q1 | $8.63M | Sell |
73,322
-848
| -1% | -$99.8K | 0.61% | 46 |
|
|
2021
Q4 | $9.61M | Buy |
+74,170
| New | +$9.61M | 0.65% | 44 |
|